Acuta Capital Partners as of Sept. 30, 2018
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 27 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 15.3 | $43M | 2.1M | 20.83 | |
| Assembly Biosciences | 14.3 | $40M | 1.1M | 37.14 | |
| Iovance Biotherapeutics (IOVA) | 8.9 | $25M | 2.2M | 11.25 | |
| Kadmon Hldgs | 8.8 | $25M | 7.4M | 3.34 | |
| Chembio Diagnostics | 7.6 | $21M | 2.0M | 10.50 | |
| Arrowhead Pharmaceuticals (ARWR) | 6.7 | $19M | 975k | 19.17 | |
| IRIDEX Corporation (IRIX) | 4.4 | $12M | 1.9M | 6.35 | |
| CAS Medical Systems | 4.3 | $12M | 5.3M | 2.28 | |
| Veracyte (VCYT) | 3.7 | $10M | 1.1M | 9.55 | |
| SPDR S&P Biotech (XBI) | 3.4 | $9.6M | 100k | 95.87 | |
| Regeneron Pharmaceuticals (REGN) | 2.9 | $8.1M | 20k | 404.05 | |
| Argenx Se (ARGX) | 2.8 | $8.0M | 105k | 75.84 | |
| Madrigal Pharmaceuticals (MDGL) | 2.5 | $7.1M | 33k | 214.12 | |
| Biohaven Pharmaceutical Holding | 2.5 | $7.0M | 186k | 37.55 | |
| Coherus Biosciences (CHRS) | 2.4 | $6.7M | 404k | 16.50 | |
| Xenon Pharmaceuticals (XENE) | 2.3 | $6.4M | 483k | 13.20 | |
| Ascendis Pharma A S (ASND) | 1.8 | $5.1M | 72k | 70.85 | |
| Acer Therapeutics | 1.2 | $3.4M | 109k | 30.84 | |
| Viewray (VRAYQ) | 1.0 | $2.9M | 312k | 9.36 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $2.8M | 129k | 22.11 | |
| Magenta Therapeutics | 0.7 | $2.0M | 170k | 12.01 | |
| Endocyte | 0.6 | $1.6M | 92k | 17.76 | |
| Amarin Corporation (AMRN) | 0.4 | $1.2M | 71k | 16.27 | |
| AMAG Pharmaceuticals | 0.3 | $800k | 40k | 20.00 | |
| Alimera Sciences | 0.1 | $262k | 268k | 0.98 | |
| Gtx Inc Del | 0.1 | $157k | 100k | 1.57 | |
| Oncobiologics | 0.0 | $29k | 29k | 1.00 |
